ISA Pharmaceuticals to Present at Business Conferences in May 2022
ISA Pharmaceuticals to Present at Business Conferences in May 2022
Oegstgeest, The Netherlands, 27 April 2022 – ISA Pharmaceuticals B.V., a clinical stage biotech company developing immunotherapies to treat cancers and infectious diseases, is pleased to announce that its representatives will be participating and presenting at the following business conferences in May 2022.
Date: 10-11 May 2022, London, UK
Panel Presentation by: Anton Mat, Director Business Development, ISA Pharmaceuticals
Title: Key Multi-Stakeholder Considerations In Early-Stage Commercial Deal-Making
Date & Time: Tuesday, 10 May 2022, 14.30pm BST
Date: 16-18 May 2022, Milan, Italy
Presentation by: Gerben Moolhuizen, Chief Executive Officer, ISA Pharmaceuticals
Date & Time: Virtual, pre-recorded presentation available any time via the partnering system
UBS Global Healthcare Conference
Date: 23-25 May 2022, New York, US
Presentation by: Gerben Moolhuizen, Chief Executive Officer, ISA Pharmaceuticals
Title: ISA Pharmaceuticals Company Presentation
Date & Time: Monday, 23 May 2022, 07.45am ET
If you would like to meet with the ISA Pharmaceuticals team at any of the above events, please contact us at the details provided below. For more information, please visit us at isa-pharma.com.
Editor Details
-
Company:
- PharmiWeb.com
-
Name:
- PW Editor
- Email:
-
Telephone:
- +441344851506
